Quidelortho CORP Form 4 insider transactions

Director Kenneth F. Buechler reports the release of restricted stock units into QuidelOrtho common stock on May 18, 2025, according to a Form 4 filing.

Director Kenneth J. Widder reports the release of restricted stock units into common stock, with no monetary transaction, according to a pre-arranged deferred compensation schedule.

Director Mary Lake Polan reports the release of restricted stock units and subsequent ownership of QuidelOrtho Corp common stock.

Brian J. Blaser, President and CEO of QuidelOrtho Corp, reports the release of restricted stock units and subsequent tax withholding transactions.

Philip D. McLellan, Chief Operations Officer of QuidelOrtho Corp, reports acquisition and disposition of common stock and restricted stock units on April 26, 2025.

Philip D. McLellan, Chief Operations Officer of QuidelOrtho Corp, reports acquisition and disposition of common stock and restricted stock units on April 22, 2025.

Michelle A. Hodges, Chief Legal Officer of QuidelOrtho Corp, reports the acquisition of restricted stock units in lieu of cash payments under a deferred compensation program.

Chief Financial Officer Joseph M. Busky reports the release of restricted stock units and subsequent disposition of shares to cover tax obligations.

Michelle Hodges, Chief Legal Officer of QuidelOrtho Corp, reports the release of restricted stock units and disposition of shares to cover tax obligations on March 28, 2025.

QuidelOrtho's CFO, Joseph M. Busky, reports the vesting and subsequent tax-related disposition of common stock.

Michelle Hodges, Chief Legal Officer of QuidelOrtho Corp, reports the release of restricted stock units and disposition of shares to cover tax obligations on February 8, 2025.

Brian Blaser, President and CEO of QuidelOrtho Corp, amends a previous SEC filing to accurately report the number of restricted stock units granted on January 29, 2025.

Michelle Hodges, Chief Legal Officer of QuidelOrtho Corp, reports the acquisition and disposition of common stock and restricted stock units related to vesting and tax obligations.

Philip D. McLellan, Chief Operations Officer of QuidelOrtho Corp, reports the vesting and subsequent tax withholding of common shares related to restricted stock units.

Philip D. McLellan, Chief Operations Officer of QuidelOrtho Corp, was granted stock options and restricted stock units on January 29, 2025.

Jonathan Philip Siegrist, EVP of R&D & CTO at QuidelOrtho Corp, was granted restricted stock units and non-qualified stock options on January 29, 2025.

Michelle A. Hodges, Chief Legal Officer of QuidelOrtho Corp, was granted stock options and restricted stock units on January 29, 2025.

QuidelOrtho's Chief Financial Officer, Joseph M. Busky, was granted 25,276 restricted stock units on January 29, 2025, which will vest over the next three years.

Ronald Lee Bowman, Chief Human Resources Officer at QuidelOrtho, acquired 8,816 restricted stock units and 8,815 non-qualified stock options on January 29, 2025.

QuidelOrtho's President and CEO, Brian J. Blaser, was granted 52,390 restricted stock units, which will vest over the next three years.

QuidelOrtho's President and CEO, Brian J. Blaser, acquired 6,033 shares of common stock through a trust on December 11, 2024.

Michelle A. Hodges, Chief Legal Officer of QuidelOrtho Corp, reported the acquisition and disposition of company stock on December 1, 2024, related to the vesting of restricted stock units and tax obligations.

Carlyle Group and related entities have reported the sale of 8,260,183 shares of QuidelOrtho Corp at a price of $35.314 per share.

Michelle A. Hodges, Chief Legal Officer at QuidelOrtho Corp, was granted 16,047 restricted stock units on November 18, 2024.

Michelle A. Hodges, Chief Legal Officer at QuidelOrtho Corp, reported the acquisition of 3,970 shares and the disposition of 1,417 shares on November 8, 2024, related to the vesting of restricted stock units.

Robert Bujarski, EVP & COO of QuidelOrtho Corp, reports the acquisition and disposition of common stock and restricted stock units on October 15, 2024.

Michelle Hodges, SVP and General Counsel of QuidelOrtho Corp, reports the release of restricted stock units and disposition of shares to cover tax obligations.

Ronald Lee Bowman, Chief Human Resources Officer of QuidelOrtho Corp, reports the acquisition of 7,697 restricted stock units.

Robert Bujarski, EVP & COO of QuidelOrtho Corp, reports the release of restricted stock units and disposition of shares to cover tax obligations on September 14, 2024.

Carlyle Group executed sales of QuidelOrtho Corp shares on August 9, 2024, under a pre-arranged Rule 10b5-1 trading plan.